BlackRock’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.41M | Buy |
718,690
+534,264
| +290% | +$6.25M | ﹤0.01% | 3441 |
|
|
2025
Q1 | $2.4M | Buy |
184,426
+10,673
| +6% | +$139K | ﹤0.01% | 3892 |
|
|
2024
Q4 | $2.19M | Buy |
173,753
+145,515
| +515% | +$1.84M | ﹤0.01% | 3954 |
|
|
2024
Q3 | $260K | Buy |
28,238
+234
| +0.8% | +$2.15K | ﹤0.01% | 4420 |
|
|
2024
Q2 | $196K | Buy |
+28,004
| New | +$196K | ﹤0.01% | 4502 |
|
|
2022
Q2 | – | Sell |
-1,150
| Closed | -$46K | – | 5760 |
|
|
2022
Q1 | $46K | Sell |
1,150
-56
| -5% | -$2.24K | ﹤0.01% | 5335 |
|
|
2021
Q4 | $53K | Buy |
1,206
+31
| +3% | +$1.36K | ﹤0.01% | 5317 |
|
|
2021
Q3 | $71K | Sell |
1,175
-231
| -16% | -$14K | ﹤0.01% | 5162 |
|
|
2021
Q2 | $101K | Buy |
+1,406
| New | +$101K | ﹤0.01% | 4971 |
|